Published: September 2025

Last updated: September 2025

From Data to Decisions: Leveraging Statistics to Improve Healthcare Decision-Making

Health economics is an important field not just in the UK but globally. Decision-makers can use it to prioritise resources used in healthcare systems to maximise population health whilst ensuring value for money. Since 1999, the National Institute for Health and Care Excellence (NICE) has been responsible for these decisions in the UK. There is a need to provide these decision-makers with the best possible evidence for new treatments to support well-informed decisions.

The vast majority of health economic modelling is still conducted using Markov models to capture disease progression. However, these models rely on restrictive assumptions that may not accurately capture real-world disease progression. This talk will discuss two examples from a recent publication
where regression modelling was used to improve the health economic model. The first example will cover using a multinomial logistic regression to predict the changes in haemoglobin health states over time in patients with chronic kidney disease. Traditional Markov models assume a fixed disease progression rate which fails to account for patient subgroups and time-varying rates. Regression models enable dynamic transitions based on patient characteristics like age, sex, and baseline haemoglobin levels. This leads to better modelling of disease progression and subsequent decision-making.

The second example will cover using a generalised linear mixed model (GLMM) to estimate drug doses for each haemoglobin health state whilst adjusting for subgroup characteristics. This allows for a more granular approach to cost-effectiveness analysis. Unlike Markov models, which often require simplifying assumptions to capture drug doses, a GLMM better reflects the uncertainty in the target-population.

As real-world evidence and individual patient data (IPD) become more accessible, alongside increasing computational power, statisticians must apply and share advanced modelling approaches. By doing so, we can enhance healthcare decision-making, ultimately leading to better policies and improved population health.

You may also be interested in

Peer-reviewed publication

The Economic and Clinical Impact of an AI-Assisted Tool for Colonoscopy to Support Diagnosis of Colorectal Cancer in Symptomatic Patients in England

YHEC authors: Luc Curtis-Gretton, Angel Varghese, Karina Watts, Hayden Holmes
Publication date: November 2026
Publishers: Springer Nature Link
Journal: BMC Digital Health

Abstract

BACKGROUND: Colorectal cancer (CRC) remains a leading cause of cancer-related mortality in the UK. Early detection and removal of adenomatous polyps are essential to improving outcomes. Artificial intelligence-assisted colonoscopy tools,...

Peer-reviewed publication

Cost-Effectiveness of Transcatheter Aortic Valve Implantation for Asymptomatic Severe Aortic Stenosis in the Kingdom of Saudi Arabia

YHEC authors: Madison Montgomery, Heather Davies, Lucy Hillcoat
Publication date: October 2026
Journal: Frontiers in Cardiovascular Medicine

Abstract

INTRODUCTION: Aortic stenosis (AS) is defined as the narrowing of the aortic valve. The benefits of implementing early aortic valve replacement (AVR), while the AS is asymptomatic, have been demonstrated...

Peer-reviewed publication

What is the Role of Multidisciplinary Methods to Support Environmental Sustainability in Health Technology Assessment?

YHEC authors: Melissa Pegg, Emma Bishop, Karina Watts
Publication date: October 2026
Publishers: HTAi
Journal: International Journal of Technology Assessment in Healthcare

Abstract

Healthcare contributes up to 8.5 percent of global carbon emissions, amongst other environmental impacts including intensive water consumption, plastics in our environment and pharmaceutical associated pollution. Healthcare supply chains are...